SRSF3 reportedly modulated the alternative splicing of several apoptosis-related genes, such as caspase-2 (Casp2), programmed cell death 4 (PDCD4), and homeodomain-interacting protein kinase-2 (HIPK2) in distinct cancer cells [109,110,111]. Here, HIPK2 is linked to cancer.